3 Stocks Estimated To Be Trading At Discounts Up To 48.8%

Simply Wall St.
08/12

As the U.S. markets experience fluctuations ahead of key economic data releases, with major indexes recently retreating from record highs, investors remain vigilant about potential shifts in monetary policy and inflationary trends. In this environment, identifying undervalued stocks can be an effective strategy for those looking to capitalize on market inefficiencies; such stocks may offer attractive entry points when broader market conditions are uncertain.

Advertisement

Top 10 Undervalued Stocks Based On Cash Flows In The United States

NameCurrent PriceFair Value (Est)Discount (Est)
Udemy (UDMY)$6.65$13.2049.6%
Royal Gold (RGLD)$170.60$331.8848.6%
Privia Health Group (PRVA)$20.31$39.6648.8%
Perfect (PERF)$1.85$3.6248.8%
Old National Bancorp (ONB)$20.57$40.2048.8%
Niagen Bioscience (NAGE)$9.82$19.0248.4%
Ligand Pharmaceuticals (LGND)$147.01$285.8648.6%
Granite Ridge Resources (GRNT)$5.25$10.2448.7%
Dayforce (DAY)$49.92$96.8348.4%
Corsair Gaming (CRSR)$9.03$17.8349.4%

Click here to see the full list of 174 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Privia Health Group (PRVA)

Overview: Privia Health Group, Inc. is a national physician-enablement company in the United States with a market cap of $2.53 billion.

Operations: The company generates revenue of $1.90 billion from its Healthcare Facilities & Services segment.

Estimated Discount To Fair Value: 48.8%

Privia Health Group is trading at US$20.31, significantly below its estimated fair value of US$39.66, suggesting undervaluation based on cash flows. Despite recent insider selling, the company has raised its 2025 revenue guidance above previous expectations and reported strong sales growth in Q2 2025 to US$521.15 million from US$422.33 million a year ago. Analysts anticipate earnings growth of over 36% annually, outpacing the broader U.S. market's expected profit growth rate.

  • Our expertly prepared growth report on Privia Health Group implies its future financial outlook may be stronger than recent results.
  • Click to explore a detailed breakdown of our findings in Privia Health Group's balance sheet health report.
PRVA Discounted Cash Flow as at Aug 2025

Apollo Global Management (APO)

Overview: Apollo Global Management, Inc. is a private equity firm specializing in credit, private equity, infrastructure, secondaries and real estate investments with a market cap of $81.21 billion.

Operations: Apollo Global Management's revenue is primarily derived from its Asset Management segment at $5.24 billion, Principal Investing at $1.15 billion, and Retirement Services at $21.40 billion.

Estimated Discount To Fair Value: 22.3%

Apollo Global Management is trading at US$142.12, below its estimated fair value of US$182.98, indicating potential undervaluation based on cash flows. The company recently priced a US$500 million debt offering to support corporate activities and acquisitions, despite reporting decreased net income in Q2 2025 compared to the previous year. Analysts forecast significant earnings growth of over 23% annually, surpassing the broader U.S. market's expectations for profit expansion.

  • Upon reviewing our latest growth report, Apollo Global Management's projected financial performance appears quite optimistic.
  • Take a closer look at Apollo Global Management's balance sheet health here in our report.
APO Discounted Cash Flow as at Aug 2025

Atlantic Union Bankshares (AUB)

Overview: Atlantic Union Bankshares Corporation is a bank holding company for Atlantic Union Bank, offering a range of banking and financial services to consumers and businesses in the United States, with a market cap of approximately $4.57 billion.

Operations: The company's revenue is primarily derived from Consumer Banking, which accounts for $376.28 million, and Wholesale Banking, contributing $411.16 million.

Estimated Discount To Fair Value: 30%

Atlantic Union Bankshares is trading at US$31.90, approximately 30% below its estimated fair value of US$45.59, suggesting undervaluation based on cash flows. Despite a decline in net income for Q2 2025 compared to the previous year, analysts forecast significant earnings growth of 46.9% annually over the next three years, outpacing the broader U.S. market's growth expectations and supporting its potential as an undervalued stock.

  • The growth report we've compiled suggests that Atlantic Union Bankshares' future prospects could be on the up.
  • Click here and access our complete balance sheet health report to understand the dynamics of Atlantic Union Bankshares.
AUB Discounted Cash Flow as at Aug 2025

Where To Now?

  • Get an in-depth perspective on all 174 Undervalued US Stocks Based On Cash Flows by using our screener here.
  • Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
  • Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Contemplating Other Strategies?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
  • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10